Skip to main content
Book Chapter

Understanding Clinical Trials in Malignant Mesothelioma

  • Mansfield A
  • Wigle D
  • Peikert T
Springer International Publishing, (2019), 187-202
DOI: 10.1007/978-3-319-96244-3_17
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

… When a drug is approved by the FDA for an indication other than mesothelioma, some patients or family … signal of efficacy against tumors with a biomarker that is also present in this patient's tumor. Some success stories have been published with this approach (Mansfield et al …

Cite

CITATION STYLE

APA

Mansfield, A., Wigle, D., & Peikert, T. (2019). Understanding Clinical Trials in Malignant Mesothelioma. In Caring for Patients with Mesothelioma: Principles and Guidelines (pp. 187–202). Springer International Publishing. https://doi.org/10.1007/978-3-319-96244-3_17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free